Our observations are consistent with previous observations highlighting the role of CCL3 and CCL4 chemokine systems in recruiting antitumor CD103+ DCs to the tumor, especially in the tumor models that respond poorly to CPIs (27, 41–43). The gene discussed is CCL4; the disease is neoplasm.